A detailed history of Humankind Investments LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Humankind Investments LLC holds 14,527 shares of ABT stock, worth $1.67 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
14,527
Previous 14,621 0.64%
Holding current value
$1.67 Million
Previous $1.52 Million 9.02%
% of portfolio
0.61%
Previous 0.41%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $9,406 - $11,104
-94 Reduced 0.64%
14,527 $1.66 Million
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $1.05 Million - $1.18 Million
10,466 Added 251.89%
14,621 $1.52 Million
Q1 2024

May 08, 2024

SELL
$109.52 - $120.96 $27,270 - $30,119
-249 Reduced 5.65%
4,155 $472,000
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $11,814 - $14,462
131 Added 3.07%
4,404 $484,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $15,762 - $18,912
165 Added 4.02%
4,273 $413,000
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $34,970 - $38,964
347 Added 9.23%
4,108 $447,000
Q1 2023

Apr 25, 2023

SELL
$96.86 - $114.01 $8,814 - $10,374
-91 Reduced 2.36%
3,761 $380,000
Q4 2022

Jan 26, 2023

BUY
$95.06 - $111.52 $21,578 - $25,315
227 Added 6.26%
3,852 $0
Q3 2022

Nov 09, 2022

BUY
$96.76 - $112.03 $63,377 - $73,379
655 Added 22.05%
3,625 $351,000
Q2 2022

Aug 05, 2022

BUY
$102.07 - $123.37 $41,032 - $49,594
402 Added 15.65%
2,970 $323,000
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $34,320 - $41,851
301 Added 13.28%
2,568 $304,000
Q4 2021

Mar 21, 2022

BUY
$115.53 - $141.46 $26,456 - $32,394
229 Added 11.24%
2,267 $319,000
Q3 2021

Mar 21, 2022

SELL
$116.66 - $129.06 $50,163 - $55,495
-430 Reduced 17.42%
2,038 $241,000
Q2 2021

Mar 21, 2022

BUY
$105.79 - $124.53 $261,089 - $307,340
2,468 New
2,468 $286,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Humankind Investments LLC Portfolio

Follow Humankind Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.